Your browser doesn't support javascript.
loading
Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease.
Ray, Balmiki; Maloney, Bryan; Sambamurti, Kumar; Karnati, Hanuma K; Nelson, Peter T; Greig, Nigel H; Lahiri, Debomoy K.
Affiliation
  • Ray B; Department of Psychiatry, Laboratory of Molecular Neurogenetics, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
  • Maloney B; Department of Psychiatry, Laboratory of Molecular Neurogenetics, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
  • Sambamurti K; Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
  • Karnati HK; Department of Neurosciences, Medical University of South Carolina, Charleston, 29425 SC, USA.
  • Nelson PT; National Institute on Aging, Drug Design and Development Section, Bethesda, MD, 20892, USA.
  • Greig NH; Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, 40536, USA.
  • Lahiri DK; National Institute on Aging, Drug Design and Development Section, Bethesda, MD, 20892, USA.
Transl Psychiatry ; 10(1): 81, 2020 Mar 02.
Article in En | MEDLINE | ID: mdl-32123156
ABSTRACT
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Psychiatry Year: 2020 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Psychiatry Year: 2020 Document type: Article Affiliation country: United States